Paper Details

  1. Home
  2. Paper Details

Efficacy of single-dose intravenous dolasetron versus ondansetron in the prevention of postoperative nausea and vomiting.

Author: WalkerJ B

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.

Overview

This study discussed the use of 5-hydroxytryptamine3-receptor antagonists, such as ondansetron, dolasetron, and granisetron, in preventing postoperative nausea and vomiting (PONV) and avoiding adverse events associated with traditional antiemetics.
Paper Details　
Original Abstract of the Article :
Postoperative nausea and vomiting (PONV) is a significant problem in surgical patients. The 5-hydroxytryptamine3-receptor antagonists ondansetron, dolasetron, and granisetron are being used to prevent PONV and avoid the adverse events associated with traditional antiemetics such as antihistaminic ag...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/s0149-2918(01)80080-1

データ提供：米国国立医学図書館（NLM）

Single-Dose Intravenous Dolasetron vs. Ondansetron for Postoperative Nausea and Vomiting: Finding Relief in the Desert of Postoperative Discomfort

The desert of postoperative discomfort can be a harsh and unpleasant experience. Postoperative nausea and vomiting (PONV) is a common complication that can significantly impact a patient's recovery. This research investigates the effectiveness of two 5-hydroxytryptamine3-receptor antagonists, dolasetron and ondansetron, in preventing PONV. The researchers conducted a study to compare the efficacy of single-dose intravenous dolasetron to ondansetron, seeking to identify a more effective treatment option for PONV.

A Promising Solution for Postoperative Discomfort

This research explores the efficacy of dolasetron, a newer 5-HT3 receptor antagonist, in preventing PONV. The findings suggest that dolasetron may be a viable alternative to ondansetron, offering potential advantages in reducing the incidence of PONV.

Navigating the Desert of Postoperative Discomfort

The desert of postoperative discomfort can be a challenging experience. It is essential to discuss your concerns about PONV with your healthcare provider before surgery. This research provides valuable insights into the potential benefits of dolasetron as a treatment for PONV, offering hope for those seeking relief in the desert of postoperative discomfort.

Dr.Camel's Conclusion

This research, like a cool breeze in the desert of postoperative discomfort, explores new options for preventing PONV. It reminds us that even in the face of challenging medical situations, there is always the possibility of finding innovative solutions to improve patient outcomes.

Date :
  1. Date Completed 2001-12-04
  2. Date Revised 2019-09-21
Further Info :

Pubmed ID

11440292

DOI: Digital Object Identifier

10.1016/s0149-2918(01)80080-1

Related Literature

Article Analysis
・Effects of dolasetron injection
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.